Updating a report from Wednesday: Phillies right-hander Jake Arrieta is set to undergo season-ending elbow surgery later this month, per MLB.com’s Todd Zolecki. The club has yet to make a formal announcement confirming the news.
Arrieta was initially placed on the 10-day injured list on Wednesday with a bone spur in his right elbow. He told reporters that he didn’t expect to pitch again in 2019, though he has no current plans to opt out of the three-year, $75 million contract he inked with the club last year. Saturday’s news confirmed that expectation, as he’ll require a lengthy recovery process following the bone spur removal.
Per Zolecki, the Phillies believe Arrieta will have plenty of time to make a complete recovery in advance of the team’s spring training in 2020. The 33-year-old righty will finish his 10th season in the majors with an 8-8 record in 24 starts, alongside a 4.64 ERA, 3.4 BB/9, 7.3 SO/9, and 1.0 fWAR through 135 2/3 innings.
Indians slugger José Ramírez broke the hamate bone on his right hand last month and had surgery on August 26 to repair it. At the time he was given the same schedule most hamate bone surgery recipients get: 5-7 weeks if all goes well. Apparently all has gone better-than-well for Ramírez, however, because the Indians are going to activate him tomorrow.
That’s good news for the Indians, who are in a dead heat with the Tampa Bay Rays for the AL’s second Wild Card with six games to go.
Ramírez, like his team, started the season slowly, but he had turned things on in July and August to help fuel Cleveland’s surge into playoff contention. He hit .320/.340/.680 with nine homers and 25 driven in in July and was hitting .321/.372/.705 with six homers and 20 driven in August when he went down. Basically, he had been a better version of the Ramírez who won the Silver Slugger Award and came in third in the MVP balloting in 2018, at least for those two months.
It’ll be interesting to see how rusty he is or if the surgery has sapped his power or bat speed. We’ll only have six games in which to see it, though.